Concepedia

Elizabeth Anscombe

EA

4

Publications

305

Citations

4

H-Index

2013

Active since

Affiliations

University of Oxford(Current)

Newcastle University

Elizabeth Anscombe is an author at University of Oxford specializing in drug discovery, pharmacotherapy, and molecular pharmacology.

Top concepts

Publications per year

2013–2021

4

Publications

4

Identification and Characterization of an Irreversible Inhibitor of CDK2

Elizabeth Anscombe, Elisa Meschini, Regina Mora-Vidal et al. · Chemistry & Biology · 2015 · 117 citations · Full text

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines

Christopher R. Coxon, Elizabeth Anscombe, Suzannah J. Harnor et al. · Journal of Medicinal Chemistry · 2016 · 113 citations · Full text

Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein–Protein Interaction

Gianni Chessari, Ian R. Hardcastle, Jong Sook Ahn et al. · Journal of Medicinal Chemistry · 2021 · 52 citations

8-Substituted <i>O</i><sup>6</sup>-Cyclohexylmethylguanine CDK2 Inhibitors: Using Structure-Based Inhibitor Design to Optimize an Alternative Binding Mode

Benoît Carbain, David J. Paterson, Elizabeth Anscombe et al. · Journal of Medicinal Chemistry · 2013 · 23 citations · Full text

, , +20

Rows per page

1–4 of 4